Johnson & Johnson plans to test a new coronavirus vaccine with 60,000 volunteers in a late-stage trial, which is set to begin in September.
What’s going on?
- Johnson & Johnson said it will conduct a trial in September in about 180 different sites across the United States, Brazil and Mexico — as well as other areas.
- “We can confirm that planning and recruitment is underway for our Phase 3 program, which is subject to interim data of the Phase 1/2a trials and approval of regulators,” a Johnson & Johnson spokesman said, per Reuters.
- Johnson & Johnson will review health data to decide where the studies take place. A final decision on locations will be made soon.
- A separate trial from Moderna and Pfizer is requiring 30,000 volunteers.
Will Americans take the vaccine?
- It’s unclear how many Americans will even take the coronavirus vaccine once it’s available. A new poll from NBC News and SurveyMonkey found that 44% of Americans said they’d get the vaccine, 22% said they wouldn’t and 32% said they’re unsure.